VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NRXP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NRXPNRx Pharmaceuticals, Inc.
$3.16$55M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNRXPQuarterly Balance Sheet

NRx Pharmaceuticals, Inc. (NRXP) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

NRx Pharmaceuticals, Inc. (NRXP) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

NRXP Balance Sheet

Quarterly statement

NRXP Balance Sheet

NRx Pharmaceuticals, Inc. (NRXP) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets29.16M7.36M8.89M11.95M4.59M7.26M3.3M4.11M4.88M3.35M6.88M13.09M19.79M21.76M25.8M24.8M32.41M43.58M32.71M45.23M
Cash & Short-Term Investments26.69M6.71M7.8M7.18M2.91M5.55M1.44M1.65M1.9M1.32M4.59M8.9M14.97M16.51M20.05M18.25M24.55M40.2M27.61M38.88M
Cash Only26.69M6.71M7.8M7.18M2.91M5.55M1.44M1.65M1.9M1.32M4.59M8.9M14.97M16.51M20.05M18.25M24.55M40.2M27.61M38.88M
Short-Term Investments00000000000000000000
Accounts Receivable206K181K161K3.33M0006K6K6K6K6K6K6K7K547K554K000
Days Sales Outstanding15.9914.41163.181.26K----------------
Inventory00000000000000-7K00000
Days Inventory Outstanding--------------------
Other Current Assets000400K00000128K00005.73M00000
Total Non-Current Assets5M4.54M4.06M3.05M248K334K349K356K384K441K431K21K21K24K21K23K19K17K15K15.92K
Property, Plant & Equipment1.75M936K696K419K0000000000000000
Fixed Asset Turnover0.82x1.31x1.76x0.58x----------------
Goodwill1.79M1.79M1.79M610K0000000000000000
Intangible Assets832K879K925K1.78M0000000000000000
Long-Term Investments402K399K397K00000000000000000
Other Non-Current Assets224K535K253K243K248K334K349K356K384K441K431K21K21K24K21K23K19K17K15K15.92K
Total Assets34.16M11.9M12.96M15M4.84M7.59M3.65M4.46M5.26M3.79M7.32M13.11M19.81M21.78M25.82M24.82M32.43M43.6M32.73M45.25M
Asset Turnover0.05x0.09x0.07x0.02x----------------
Asset Growth %606.08%56.82%254.86%236.08%-8.09%100.37%-50.09%-65.96%-73.43%-82.61%-71.66%-47.19%-38.92%-50.05%-21.12%-45.14%74.87%623.34%1012.85%650.2%
Total Current Liabilities33.87M25.18M28.58M40.59M40.45M32.75M21.86M20.3M23.66M18.86M19.05M19.33M22.62M22.06M15.59M8.04M7.08M11.91M11.92M36.28M
Accounts Payable3.15M4.4M4.27M4.26M3.63M4.31M4.13M4.87M5.01M6.26M4.63M3.63M2.21M3.78M2.08M2.17M3.08M4.31M3.69M5.56M
Days Payables Outstanding407.23490.08772.132.63K--413.82K227.26K513.24K495.81K380.1K134.23K272.14K263.34K195.22K241.32K336.2K359.91K1000K852.78K
Short-Term Debt790K0316K10.06M10.23M8.4M1.57M3.68M8.59M6.78M9.16M10.07M12.69M12.19M7.7M00520K518K515.06K
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities18.55M14.8M23.5M21M21.42M15.12M10.93M11.35M9.6M26K4.42M10K36K25K5.81M56K19K2.61M4.87M27.06M
Current Ratio0.86x0.29x0.31x0.29x0.11x0.22x0.15x0.20x0.21x0.18x0.36x0.68x0.87x0.99x1.66x3.08x4.58x3.66x2.74x1.25x
Quick Ratio0.86x0.29x0.31x0.29x0.11x0.22x0.15x0.20x0.21x0.18x0.36x0.68x0.87x0.99x1.66x3.08x4.58x3.66x2.74x1.25x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities456K543K315K158K005.01M2.98M0000002.82M00000
Long-Term Debt0000005.01M2.98M0000002.82M00000
Capital Lease Obligations456K543K315K158K0000000000000000
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities00000000000000000000
Total Liabilities34.33M25.72M28.89M40.75M40.45M32.75M26.87M23.28M23.66M18.86M19.05M19.33M22.62M22.06M18.41M8.04M7.08M11.91M11.92M36.28M
Total Debt1.25M934K631K10.41M10.23M8.4M6.58M6.67M8.59M6.78M9.16M10.07M12.69M12.19M10.53M00520K518K515.06K
Net Debt-25.44M-5.78M-7.17M3.22M7.32M2.85M5.13M5.02M6.7M5.46M4.57M1.17M-2.28M-4.32M-9.53M-18.25M-24.55M-39.68M-27.09M-38.37M
Debt / Equity--------------1.42x--0.02x0.02x0.06x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-67.83x-5.14x1.54x------8.30x-27.38x-53.15x-150.55x------4481.67x-13135.97x-6900.89x
Total Equity-170K-13.82M-15.94M-25.75M-35.62M-25.16M-23.22M-18.82M-18.39M-15.07M-11.73M-6.22M-2.81M-284K7.41M16.78M25.35M31.69M20.81M8.97M
Equity Growth %99.52%45.09%31.37%-36.83%-93.65%-66.97%-97.93%-202.75%-554.95%-5205.99%-258.36%-137.05%-111.08%-100.9%-64.39%87.14%245.39%2497.37%147.53%180.13%
Book Value per Share-0.00-0.43-0.50-1.16-1.99-1.53-2.21-1.72-1.75-1.70-0.14-0.76-0.04-0.000.110.250.390.500.400.16
Total Shareholders' Equity-170K-13.82M-15.94M-25.75M-35.62M-25.16M-23.22M-18.82M-18.39M-15.07M-11.73M-6.22M-2.81M-284K7.41M16.78M25.35M31.69M20.81M8.97M
Common Stock43K33K32K28K19K17K15K11K11K10K84K84K80K70K67K68K67K67K59K54.81K
Retained Earnings-324.85M-308.32M-306.89M-307.26M-301.37M-283.79M-278.27M-269.19M-267.57M-259.68M-253.15M-248.81M-242.75M-234.04M-223M-212.76M-203.67M-196.69M-183.24M-152.45M
Treasury Stock00000000000000000000
Accumulated OCI00000000-3K-3K-3K-22K-22K106K000000
Minority Interest00000000000000000000